Changmao Biochemical Engineering Company Limited ("Changmao") was established in 1992. It was listed on GEM Board of HK Stock Exchange in 2002 and transferred to the Main Board in 2013 (stock code: 00954.HK). Changmao is recognized as a Jiangsu Hi-tech Enterprise and Jiangsu Foreign-invested Advanced Technology Enterprise. In 1998, Changmao established the "Biochemical Chirotechnology Research Center in Jiangsu." It acquired "Shanghai Medical Life Science Research Centre Limited (Shanghaimed CO.,LTD.)" in 2006 and subsequently established "Shanghai Changmao Biochemical Engineering Company Limited" in 2007. "Changmao
Biochemical Lianyungang Company Limited" was founded in 2012.

Changmao is a leading producer and seller of food additives. It is the largest L(+)-tartaric acid producer in the world and the largest L-malic acid producer in China. Its core products include L(+)-tartaric acid, L-malic acid, fumaric acid, maleic acid and other organic acids as well as the sweetener Aspartame. Changmao has production bases, one at the headquarters in Changzhou city and the other in Lianyungang city. Lianyungang.

While mainly found in food, Changmao products are also widely used in different areas including pharmaceutical and chemical industries. With a world-wide business approach, the company's major clients are domestic and internationally renowned food enterprises. With most of its products exported to Japan, Europe, Australia, the United States and the Middle East, Changmao has built a good reputation in international markets. has been awarded as a renowned trademark in China and thebrand is well recognized by customers.

Changmao has made instrumental contributions to establishing national standards for L-malic acid and other products, underscoring its strong industry-leading position. Changmao considers quality first and foremost and understands that it is the life blood of the company. All of the products meet the most demanding international quality standards including Food Chemicals Codex, U.S.Pharmacopoeia, and British Pharmacopoeia. The products have obtained the certifications of Star-K Kosher and HALAL, ISO, HACCP, ISO14001 and FSSC22000. The company's L(+)-tartaric acid was affirmed GRAS qualification by the Food and Drug Administration (FDA) in the U.S. The certifications demonstrate global recognition of Changmao's quality from high-end customers.

The long term development of Changmao is led by its strong R&D and innovation capability. Its R&D professionals currently account for about 15% of the company's total staff. To boost its research prowess, the company has also strengthened collaboration with major research institutes and universities including Tsinghua University, Fudan University and the Chinese Academy of Sciences on selected R&D projects.

Maintaining superior quality, excellent service, and a well-respected reputation, Changmao seeks to establish long term mutually beneficial overseas business partnerships and to contribute to the happy lives of our customers.